ARWR

#941
Arrowhead Research Corporation
66.2300 USD
+3.83%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
66.1100
66.4200
Intervallo Annuale
37.0600
76.7600
Variazione giornaliera
+3.83%
Variazione Mensile
+18.27%
Variazione di 6 mesi
+69.39%
Variazione Annuale
+69.39%
Chiusura Precedente
63.7900
Apertura
66.3400
Bid
Ask
Minimo
66.1100
High
66.4200
Volume
84
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 9.2743 B
  • Employee 711
  • Founded 2004
  • CEO Christopher Richard Anzalone
  • Website www.arrowheadpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRVKH0
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3 449
Rapporto prezzo/fatturato
5.56

Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

Notizie